Morgan Stanley’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.19M | Sell |
32,916
-26,094
| -44% | -$5.03M | ﹤0.01% | 3969 |
|
|
2025
Q4 | $11.2M | Buy |
59,010
+27,350
| +86% | +$5.06M | ﹤0.01% | 3516 |
|
|
2025
Q3 | $5.25M | Buy |
31,660
+349
| +1% | +$56.9K | ﹤0.01% | 4110 |
|
|
2025
Q2 | $4.8M | Sell |
31,311
-45,661
| -59% | -$6.8M | ﹤0.01% | 4091 |
|
|
2025
Q1 | $12.1M | Sell |
76,972
-14,670
| -16% | -$2.38M | ﹤0.01% | 3167 |
|
|
2024
Q4 | $14.4M | Buy |
91,642
+19,327
| +27% | +$3.25M | ﹤0.01% | 3062 |
|
|
2024
Q3 | $12.8M | Buy |
72,315
+267
| +0.4% | +$47.4K | ﹤0.01% | 3230 |
|
|
2024
Q2 | $12.1M | Buy |
72,048
+1,189
| +2% | +$194K | ﹤0.01% | 3165 |
|
|
2024
Q1 | $11.8M | Sell |
70,859
-60,255
| -46% | -$9.98M | ﹤0.01% | 3207 |
|
|
2023
Q4 | $21.7M | Buy |
131,114
+63,817
| +95% | +$9.82M | ﹤0.01% | 3259 |
|
|
2023
Q3 | $10.5M | Sell |
67,297
-1,616
| -2% | -$258K | ﹤0.01% | 3089 |
|
|
2023
Q2 | $10.8M | Sell |
68,913
-3,237
| -4% | -$517K | ﹤0.01% | 3083 |
|
|
2023
Q1 | $11.7M | Sell |
72,150
-2,837
| -4% | -$459K | ﹤0.01% | 2996 |
|
|
2022
Q4 | $12M | Buy |
74,987
+12,375
| +20% | +$1.96M | ﹤0.01% | 2901 |
|
|
2022
Q3 | $8.81M | Sell |
62,612
-12,436
| -17% | -$1.88M | ﹤0.01% | 3110 |
|
|
2022
Q2 | $10.9M | Buy |
75,048
+3,158
| +4% | +$470K | ﹤0.01% | 2985 |
|
|
2022
Q1 | $11.7M | Sell |
71,890
-16,666
| -19% | -$2.7M | ﹤0.01% | 2730 |
|
|
2021
Q4 | $16.8M | Buy |
88,556
+18,838
| +27% | +$3.63M | ﹤0.01% | 2342 |
|
|
2021
Q3 | $14.1M | Buy |
69,718
+6,908
| +11% | +$1.45M | ﹤0.01% | 2498 |
|
|
2021
Q2 | $12.7M | Sell |
62,810
-1,125
| -2% | -$209K | ﹤0.01% | 2705 |
|
|
2021
Q1 | $11.2M | Sell |
63,935
-2,415
| -4% | -$437K | ﹤0.01% | 2530 |
|
|
2020
Q4 | $11.3M | Buy |
66,350
+249
| +0.4% | +$41K | ﹤0.01% | 2381 |
|
|
2020
Q3 | $10.7M | Sell |
66,101
-1,104
| -2% | -$180K | ﹤0.01% | 1969 |
|
|
2020
Q2 | $10.9M | Buy |
67,205
+22,113
| +49% | +$3.36M | ﹤0.01% | 1889 |
|
|
2020
Q1 | $5.77M | Sell |
45,092
-728
| -2% | -$98.1K | ﹤0.01% | 2318 |
|
|
2019
Q4 | $6.39M | Buy |
45,820
+236
| +0.5% | +$31K | ﹤0.01% | 2913 |
|
|
2019
Q3 | $5.38M | Sell |
45,584
-1,375
| -3% | -$171K | ﹤0.01% | 2796 |
|
|
2019
Q2 | $6.05M | Sell |
46,959
-9,827
| -17% | -$1.21M | ﹤0.01% | 2720 |
|
|
2019
Q1 | $7.3M | Sell |
56,786
-3,186
| -5% | -$402K | ﹤0.01% | 2351 |
|
|
2018
Q4 | $6.64M | Sell |
59,972
-1,728
| -3% | -$209K | ﹤0.01% | 2553 |
|
|
2018
Q3 | $8.39M | Buy |
61,700
+675
| +1% | +$87.8K | ﹤0.01% | 2593 |
|
|
2018
Q2 | $7.32M | Sell |
61,025
-16,001
| -21% | -$1.89M | ﹤0.01% | 2725 |
|
|
2018
Q1 | $9.27M | Sell |
77,026
-18,376
| -19% | -$2.31M | ﹤0.01% | 2416 |
|
|
2017
Q4 | $11.9M | Buy |
95,402
+8,609
| +10% | +$1.1M | ﹤0.01% | 2222 |
|
|
2017
Q3 | $11.6M | Sell |
86,793
-931
| -1% | -$121K | ﹤0.01% | 2126 |
|
|
2017
Q2 | $11M | Buy |
87,724
+10,832
| +14% | +$1.31M | ﹤0.01% | 2086 |
|
|
2017
Q1 | $9.15M | Sell |
76,892
-10,352
| -12% | -$1.21M | ﹤0.01% | 2288 |
|
|
2016
Q4 | $9.38M | Buy |
87,244
+12,884
| +17% | +$1.4M | ﹤0.01% | 2321 |
|
|
2016
Q3 | $8.57M | Buy |
74,360
+4,553
| +7% | +$519K | ﹤0.01% | 2147 |
|
|
2016
Q2 | $7.14M | Sell |
69,807
-121,856
| -64% | -$13M | ﹤0.01% | 2267 |
|
|
2016
Q1 | $19.9M | Buy |
191,663
+42,383
| +28% | +$4.42M | 0.01% | 1312 |
|
|
2015
Q4 | $19M | Buy |
149,280
+46,304
| +45% | +$5.67M | 0.01% | 1446 |
|
|
2015
Q3 | $11.8M | Sell |
102,976
-26,993
| -21% | -$3.57M | ﹤0.01% | 1800 |
|
|
2015
Q2 | $17.5M | Buy |
129,969
+3,899
| +3% | +$518K | 0.01% | 1614 |
|
|
2015
Q1 | $16.3M | Sell |
126,070
-47,406
| -27% | -$5.96M | 0.01% | 1622 |
|
|
2014
Q4 | $20M | Buy |
173,476
+102,243
| +144% | +$11.5M | 0.01% | 1492 |
|
|
2014
Q3 | $7.54M | Buy |
71,233
+15,836
| +29% | +$1.6M | ﹤0.01% | 2280 |
|
|
2014
Q2 | $5.28M | Sell |
55,397
-16,557
| -23% | -$1.48M | ﹤0.01% | 2631 |
|
|
2014
Q1 | $6.54M | Buy |
71,954
+15,378
| +27% | +$1.49M | ﹤0.01% | 2331 |
|
|
2013
Q4 | $5.01M | Sell |
56,576
-1,821
| -3% | -$152K | ﹤0.01% | 2562 |
|
|
2013
Q3 | $4.83M | Buy |
58,397
+12,289
| +27% | +$965K | ﹤0.01% | 2450 |
|
|
2013
Q2 | $3.16M | Buy |
+46,108
| New | +$3.21M | ﹤0.01% | 2760 |
|
Other funds holding BBH
MIM
CCA
BFG
PPWM
Morgan Stanley's BBH Position: Q1 2026 in Review
Morgan Stanley reduced its VanEck Biotech ETF (BBH) stake by 44% in Q1 2026, selling an estimated $5.03M and leaving 32,916 shares worth $6.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3969.
Morgan Stanley first reported a position in BBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.7M in Q4 2023. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Morgan Stanley held 32,916 shares of VanEck Biotech ETF worth $6.19M as of Q1 2026.
- Morgan Stanley sold 26,094 VanEck Biotech ETF shares in Q1 2026, an estimated $5.03M.
- VanEck Biotech ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3969 holding.
- Morgan Stanley first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's VanEck Biotech ETF position peaked at $21.7M in Q4 2023.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.